跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,149 条关于
“SAR-bisFAP”
全部
11,149
临床试验
7,030
药物
2,535
机构
475
资讯
1,109
去年
INOVIQ's Exosome Therapy Shows Promise in Triple-Negative Breast Cancer
2年前
Clarity Pharmaceuticals' 67Cu-SAR-bisPSMA Shows Promise in mCRPC Trial
去年
Clarity Pharmaceuticals and Nucleus RadioPharma Collaborate on 67Cu-SAR-bisPSMA Phase 3 Trial
去年
Clarity Pharmaceuticals' 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA Gain FDA Fast Track Designations for Prostate Cancer
去年
Belzupacap Sarotalocan Shows Promise in Early-Stage Bladder Cancer Trial
2年前
Clarity's 64Cu-SAR-bisPSMA Shows Promise in Detecting Prostate Cancer Recurrence in COBRA Trial
4年前
Clarity Pharmaceuticals Completes Dosimetry Phase of SAR-bisPSMA Theranostic Trial for Metastatic Prostate Cancer
去年
Clarity Pharmaceuticals' 64Cu-SAR-bisPSMA Evaluated in Head-to-Head Prostate Cancer Imaging Trial
去年
Clarity Pharmaceuticals and SpectronRx Partner for Phase III Trial Manufacturing of Cu-64 SAR-bisPSMA
去年
Clarity Pharmaceuticals Secures Major Manufacturing Deal to Scale Cu-SAR-bisPSMA Production for Prostate Cancer Diagnostics
第 1 页,共 111 页
上一页
下一页